Bonus BioGroup Ltd. (TLV: BONS)
Israel
· Delayed Price · Currency is ILS · Price in ILA9.30
+0.20 (2.20%)
Dec 19, 2024, 5:02 PM IDT
Bonus BioGroup Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -29.47 | -28.53 | -38.7 | -90.08 | -22.02 | -22.24 | Upgrade
|
| Depreciation & Amortization | 2.79 | 2.76 | 2.66 | 1.48 | 1.07 | 1.08 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 7.9 | 20.98 | 2.15 | 0.68 | Upgrade
|
| Stock-Based Compensation | 1.49 | 1.45 | 7.6 | 9.85 | 2.75 | 4.84 | Upgrade
|
| Other Operating Activities | 0.32 | -0.75 | -6.93 | 26.34 | -0.02 | 0.19 | Upgrade
|
| Change in Accounts Receivable | -0.38 | 0.35 | 0.36 | -0.52 | -0.45 | 0.24 | Upgrade
|
| Change in Accounts Payable | 0.32 | -0.38 | -2.35 | 2.44 | 0.08 | 0.26 | Upgrade
|
| Change in Other Net Operating Assets | 1.94 | -1.3 | 0.64 | -10.33 | 0.69 | 1.84 | Upgrade
|
| Operating Cash Flow | -22.99 | -26.4 | -28.82 | -39.84 | -15.75 | -13.11 | Upgrade
|
| Capital Expenditures | -0.42 | -0.82 | -6.39 | -5.81 | -0.25 | -0.19 | Upgrade
|
| Investment in Securities | 9.14 | -13.43 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | - | 0.1 | -0.37 | - | - | Upgrade
|
| Investing Cash Flow | 8.72 | -14.26 | -6.29 | -6.18 | -0.25 | -0.19 | Upgrade
|
| Long-Term Debt Repaid | - | -1.16 | -1.2 | -1.65 | -0.67 | -0.66 | Upgrade
|
| Total Debt Repaid | -1.25 | -1.16 | -1.2 | -1.65 | -0.67 | -0.66 | Upgrade
|
| Net Debt Issued (Repaid) | -1.25 | -1.16 | -1.2 | -1.65 | -0.67 | -0.66 | Upgrade
|
| Issuance of Common Stock | - | - | 3.34 | 111.35 | 32.59 | 5.58 | Upgrade
|
| Other Financing Activities | 0.9 | - | - | 3.72 | - | - | Upgrade
|
| Financing Cash Flow | -0.35 | -1.16 | 2.14 | 113.42 | 31.92 | 4.92 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.09 | 1.12 | 7.05 | -3.94 | 0.06 | -0.15 | Upgrade
|
| Net Cash Flow | -14.52 | -40.69 | -25.93 | 63.46 | 15.98 | -8.54 | Upgrade
|
| Free Cash Flow | -23.41 | -27.22 | -35.2 | -45.65 | -16 | -13.3 | Upgrade
|
| Free Cash Flow Per Share | - | -0.02 | -0.03 | -0.04 | -0.02 | -0.02 | Upgrade
|
| Cash Interest Paid | 0.81 | 0.86 | 0.9 | 0.34 | 0.41 | 0.42 | Upgrade
|
| Levered Free Cash Flow | -12.05 | -17.26 | -20.47 | -44.15 | -8.53 | -4.99 | Upgrade
|
| Unlevered Free Cash Flow | -11.56 | -16.73 | -19.91 | -43.8 | -8.27 | -4.71 | Upgrade
|
| Change in Net Working Capital | -2.71 | 1.5 | 0.63 | 8.86 | -0.32 | -2.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.